<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00471601</url>
  </required_header>
  <id_info>
    <org_study_id>07-024</org_study_id>
    <secondary_id>P30CA008748</secondary_id>
    <secondary_id>MSKCC-07024</secondary_id>
    <nct_id>NCT00471601</nct_id>
  </id_info>
  <brief_title>Development of a Questionnaire to Evaluate Patient Expectations for Breast Reconstruction in Women With Breast Cancer or Other Conditions</brief_title>
  <official_title>Measuring Patient Expectations for Breast Reconstruction: Development and Validation of a Patient-Reported Outcomes Instrument</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Memorial Sloan Kettering Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
    <collaborator>
      <agency>McMaster University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University College, London</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The New School for Social Research</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Memorial Sloan Kettering Cancer Center</source>
  <brief_summary>
    <textblock>
      RATIONALE: A questionnaire that evaluates a patient's expectations about breast&#xD;
      reconstruction surgery may help doctors improve patient education before surgery and increase&#xD;
      patient satisfaction after surgery.&#xD;
&#xD;
      PURPOSE: This clinical trial is developing a questionnaire to evaluate patient expectations&#xD;
      for breast reconstruction in women with breast cancer or other conditions.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:&#xD;
&#xD;
        -  Develop and validate a questionnaire to evaluate preoperative expectations about breast&#xD;
           reconstruction in women with breast cancer or other conditions.&#xD;
&#xD;
        -  Determine variations in expectations related to patient characteristics.&#xD;
&#xD;
        -  Develop educational modules to help patients understand realistic outcomes.&#xD;
&#xD;
        -  Identify patient groups at risk for dissatisfaction.&#xD;
&#xD;
      OUTLINE: This is a 3-part study.&#xD;
&#xD;
        -  Part 1 (first 80 patients): Both preoperative and postoperative patients (50 patients&#xD;
           total) undergo an interview by a research study assistant about their expectations for&#xD;
           breast reconstructive surgery. Some of these patients will also complete a pilot version&#xD;
           of a questionnaire about their expectations for breast reconstructive surgery (30&#xD;
           patients total).&#xD;
&#xD;
        -  Part 2 (next 200 patients): Preoperative patients complete questionnaires (the&#xD;
           preliminary questionnaire developed after part 1 and the MSKCC BREAST-Q [Reconstruction&#xD;
           Module]) about their expectations for breast reconstructive surgery after patient&#xD;
           education about breast reconstructive surgery. Some of these patients (100 patients)&#xD;
           also complete the Brief Cope addressing emotional expression and emotional processing&#xD;
           styles of coping, Impact of Events Scale, and Life Orientation Test-Revised (LOT-R)&#xD;
           questionnaires.&#xD;
&#xD;
        -  Part 3 (final 200 patients): Preoperative patients complete a questionnaire (final&#xD;
           questionnaire developed after part 2) about their expectations for breast reconstructive&#xD;
           surgery after patient education about breast reconstruction and once after surgery.&#xD;
           Patients also complete the Breast Reconstruction Outcomes Questionnaire (MSKCC BREAST-Q)&#xD;
           once before surgery (after patient education) and once after surgery measuring patient&#xD;
           satisfaction and quality of life. A small group of patients complete the Body Image&#xD;
           Scale (BIS) and the LOT-R addressing body image, sexuality, personal well-being, and&#xD;
           lifestyle.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>March 2007</start_date>
  <completion_date type="Anticipated">September 2022</completion_date>
  <primary_completion_date type="Anticipated">September 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Item reduction</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Psychometric evaluation</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">357</enrollment>
  <condition>Breast Cancer</condition>
  <arm_group>
    <arm_group_label>Interviews/Questionnaires</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The primary intervention in part 1 includes the interview for item generation with 50 women and the pilot-testing with a separate group of n = 30 women. The primary intervention in part 2 and 3 is the administration of the questionnaire. In part 3, along with the questionnaire being developed, the Body Image Scale (BIS), the Life Orientation Test-Revised (LOT-R), and the upcoming MSKCC BREAST-Q will be given to determine convergent and discriminant construct validity. No other therapeutic or diagnostic agents will be administered.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>counseling intervention</intervention_name>
    <arm_group_label>Interviews/Questionnaires</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>questionnaire administration</intervention_name>
    <arm_group_label>Interviews/Questionnaires</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>psychosocial assessment and care</intervention_name>
    <arm_group_label>Interviews/Questionnaires</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>quality-of-life assessment</intervention_name>
    <arm_group_label>Interviews/Questionnaires</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Female.&#xD;
&#xD;
          -  Age &gt; or = to 18 to 75 years.&#xD;
&#xD;
          -  Patients who are presenting for consultation about breast reconstruction&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Inability to speak or understanding English&#xD;
&#xD;
          -  Inability to provide meaningful informed consent due to physical, cognitive, or&#xD;
             psychiatric disability.&#xD;
&#xD;
          -  Prior breast reconstruction surgery.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Colleen McCarthy, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Memorial Sloan Kettering Cancer Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Peter G. Cordeiro, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Memorial Sloan Kettering Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>New School for Social Research</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10003</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Memorial Sloan Kettering Cancer Center</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10065</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>McMaster Children's Hospital at Hamilton Health Sciences</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 3Z5</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University College of London Hospitals</name>
      <address>
        <city>London</city>
        <state>England</state>
        <zip>WIT 3AA</zip>
        <country>United Kingdom</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United Kingdom</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mskcc.org/mskcc/html/44.cfm</url>
    <description>Memorial Sloan Kettering Cancer Center</description>
  </link>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>May 8, 2007</study_first_submitted>
  <study_first_submitted_qc>May 8, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 10, 2007</study_first_posted>
  <last_update_submitted>October 1, 2021</last_update_submitted>
  <last_update_submitted_qc>October 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 4, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>recurrent breast cancer</keyword>
  <keyword>stage IA breast cancer</keyword>
  <keyword>stage IB breast cancer</keyword>
  <keyword>stage II breast cancer</keyword>
  <keyword>stage IIIA breast cancer</keyword>
  <keyword>stage IIIB breast cancer</keyword>
  <keyword>stage IIIC breast cancer</keyword>
  <keyword>stage IV breast cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Breast Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

